sodium hyaluronate (IBSA Group)

Sinovial Forte is a viscosupplementation medical device developed by IBSA Farmaceutici Italia, containing a 1.6% buffered physiological solution of sodium hyaluronate (32 mg/2 ml). It is designed for intra-articular injection to treat pain and reduced mobility associated with osteoarthritis, degenerative joint conditions, and post-traumatic joint alterations. The product acts as a temporary substitute for synovial fluid, restoring its viscoelastic properties to provide lubrication and shock absorption within the joint. The sodium hyaluronate used is obtained through fermentation and is not chemically modified, ensuring high tolerability and localized action without systemic effects. It is typically administered by a physician at weekly intervals for a total of three weeks.

Brand names

Sinovial Forte

Other names

Sinovial Forte 1.6%hyaluronic acid sodium salt